Skip to Content
COVID-19 Resources
Developmental Therapeutics Program (DTP)
Contact DTP
Show menu
Search this site
Last Updated: 05/06/21

Office of the Associate Director (OAD)

DTP provides resources and services to both public and private research communities, maintains a robust infrastructure for anti-cancer drug discovery and development, and manages a large portfolio of grants pertinent to drug discovery and biochemical pharmacology. Upon request, DTP also provides advice on drug development issues regarding chemistry, manufacturing & control, pharmacology & toxicology, and IND requirements.

DTP/OAD provides planning, implementation, coordination and oversight for all DTP activities.

OAD Staff:

Name Position Email
Dr. Rose Aurigemma Acting Associate Director
Dr. Sharad Verma Acting Deputy Associate Director
Dr. Paul G Grothaus Chemist
Dr. Brian D. Peyser Special Assistant to DTP Associate Director
Larry Anderson Chemist
Bernadette Carter Program Assistant

About the Acting Associate Director

Rosemarie Aurigemma, Ph.D. Rosemarie Aurigemma, Ph.D., has been a programmatic leader in drug development for over 20 years. Her tenure as the Deputy Associate Director of DTP resulted in the launch of the Stepping Stones preclinical development program as well as the initiation and expansion of biopharmaceutical manufacturing support for adoptive cell therapies. She was appointed as Acting Associate Director of the DCTD Developmental Therapeutics Program in January 2021. More…